Provido, Michael M.
HRN: 26-33-46 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/04/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
12/04/2024
12/11/2024
IVTT
600mg
Q8
Fracture
Waiting Final Action
Indication: Empiric Type of Infection: Bone & Joint Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes